Open AccessMethylation of somatostatin receptor 2 gene in neuroendocrine tumours as a predictor of tumour response to peptide receptor radionuclide therapy
Author(s) -
Shamus Butt,
Joanne Evans,
Francesco Mauri,
Rohini Sharma
Publication year - 2019
Publication title -
clinical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.531
H-Index - 56
eISSN - 1473-4893
pISSN - 1470-2118
DOI - 10.7861/clinmedicine.19-2-s123
Subject(s) - radionuclide therapy , somatostatin receptor , peptide receptor , medicine , somatostatin , receptor , cancer research , neuroendocrine tumors , oncology , somatostatin receptor 3 , methylation , somatostatin analogue , genetic enhancement , endocrinology , gene , somatostatin receptor 2 , octreotide , biology , genetics